Inari Medical Other Operating Income or Expenses 2019-2024 | NARI
Inari Medical other operating income or expenses from 2019 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
| Inari Medical Annual Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| 2018 | $ |
| Inari Medical Quarterly Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-7 |
| 2024-06-30 | $-7 |
| 2024-03-31 | $-9 |
| 2023-12-31 | |
| 2023-09-30 | $-3 |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $4.664B | $0.494B |
| Inari Medical, Inc. is a commercial-stage medical device company committed toward developing products to treat and change the lives of patients suffering from venous diseases. Its initial product offering comprises 2 minimally-invasive, novel catheter-based mechanical thrombectomy devices. It built its products purposely on the basis of the specific characteristics of the venous system and the treatment of the two distinct indications of venous thromboembolism or VTE (deep vein thrombosis and pulmonary embolism/ PE). Its FlowTriever product is the first thrombectomy system, which is FDA-cleared, used for the treatment of PE. Its advanced systems & processes to control the key relationships between its sales representatives and treating physicians like cardiologists, radiologists, helps it to quickly iterate products, launch and execute physician education and training programs and scale its sales organization. The company markets and sells its products to hospitals across the U.S. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $228.640B | 27.34 |
| Intuitive Surgical (ISRG) | United States | $203.692B | 93.44 |
| Alcon (ALC) | Switzerland | $44.930B | 30.06 |
| Edwards Lifesciences (EW) | United States | $42.731B | 27.14 |
| IQVIA Holdings (IQV) | United States | $36.547B | 20.14 |
| IDEXX Laboratories (IDXX) | United States | $34.559B | 40.70 |
| DexCom (DXCM) | United States | $33.915B | 51.08 |
| Mettler-Toledo (MTD) | United States | $28.793B | 35.76 |
| Waters (WAT) | United States | $24.670B | 36.48 |
| STERIS (STE) | Ireland | $21.780B | 25.07 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.792B | 0.00 |
| Hologic (HOLX) | United States | $16.284B | 17.68 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.594B | 14.98 |
| Globus Medical (GMED) | United States | $12.625B | 31.97 |
| Sysmex ADR (SSMXY) | Japan | $12.004B | 0.00 |
| Penumbra (PEN) | United States | $10.246B | 100.36 |
| Masimo (MASI) | United States | $9.328B | 45.14 |
| Glaukos (GKOS) | United States | $8.626B | 0.00 |
| Teleflex (TFX) | United States | $8.371B | 13.35 |
| Integer Holdings (ITGR) | United States | $4.770B | 27.04 |
| PROCEPT BioRobotics (PRCT) | United States | $3.783B | 0.00 |
| Veracyte (VCYT) | United States | $3.525B | 105.77 |
| LivaNova (LIVN) | United Kingdom | $2.712B | 15.66 |
| Nihon Kohden (NHNKY) | Japan | $2.552B | 19.39 |
| Tandem Diabetes Care (TNDM) | United States | $2.434B | 0.00 |
| TransMedics (TMDX) | United States | $2.267B | 71.86 |
| Elekta AB (EKTAY) | Sweden | $2.252B | 20.24 |
| Integra LifeSciences Holdings (IART) | United States | $2.014B | 10.52 |
| Alphatec Holdings (ATEC) | United States | $1.672B | 0.00 |
| RxSight (RXST) | United States | $1.365B | 0.00 |
| Artivion (AORT) | United States | $1.298B | 86.00 |
| Pulse Biosciences (PLSE) | United States | $1.288B | 0.00 |
| Paragon 28 (FNA) | United States | $1.090B | 0.00 |
| OPKO Health (OPK) | United States | $1.037B | 0.00 |
| AxoGen (AXGN) | United States | $0.801B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.791B | 13.45 |
| IRadimed (IRMD) | United States | $0.750B | 40.56 |
| Mesa Laboratories (MLAB) | United States | $0.748B | 17.63 |
| SiBone (SIBN) | United States | $0.703B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.700B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.626B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.581B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.499B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.482B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.482B | 25.35 |
| AngioDynamics (ANGO) | United States | $0.462B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.422B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.420B | 22.74 |
| NeuroPace (NPCE) | United States | $0.411B | 0.00 |
| CVRx (CVRX) | United States | $0.388B | 0.00 |
| Inogen (INGN) | United States | $0.278B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.259B | 0.00 |
| Accuray (ARAY) | United States | $0.224B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.223B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.201B | 0.00 |
| Nevro (NVRO) | United States | $0.190B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.142B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.135B | 14.45 |
| LENSAR (LNSR) | United States | $0.129B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.106B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| Neuronetics (STIM) | United States | $0.094B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.091B | 0.00 |
| 908 Devices (MASS) | United States | $0.087B | 0.00 |
| Hyperfine (HYPR) | United States | $0.080B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.079B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.077B | 0.00 |
| InspireMD (NSPR) | Israel | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.058B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.057B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.056B | 29.43 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.047B | 0.00 | |
| Microbot Medical (MBOT) | United States | $0.037B | 0.00 |
| Spectral AI (MDAI) | United States | $0.036B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.026B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.021B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.018B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |